- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06258941
The Effects of 12-Week High-intensity Interval Training With Mindfulness-based Recovery on Executive Function, Fitness, and Mindfulness in Children
Supporting High-intensity Interval Training With Mindfulness for Enhancing Childhood Executive Function
The goal of this randomized controlled trial is to learn about the effect of a 12-week school-based intervention combining mindfulness with high-intensity interval training (MF-HIIT), MF-only intervention, and HIIT-only intervention in relative to sedentary activities on executive function (EF) in 10-12 years old children. The main question it aims to answer is whether a 12-week school-based MF-HIIT intervention has larger beneficial effect on EF performance than that following a 12-week school-based MF-only and HIIT-only in relative to the sedentary activities.
Multiple cohorts of participants will be recruited to participate this one-semester study, including the pretest, intervention, and posttest phases.
During the pretest phase, participants an their parents will complete the following
- Kaufman Brief Intelligence Test (KBIT) to assess intelligence quotient
- Fitnessgram test to assess aerobic capacity, muscle endurance, flexibility, and body mass index
- Child and Adolescent Mindfulness Measure (CAMM) questionnaire to assess dispositional mindfulness
- Computerized tasks to assess EF
- Parent-reported demographic and health information
Following the pretest phase, participants will receive the 12-week classroom-based intervention, with the classroom as the intervention unit.
Following the intervention and during the posttest phase, participants will complete the fitness, measures, EF measures, and dispositional mindfulness measure again.
Researcher will compare the EFn outcome measures following the MF-HIIT, MF-only, and HIIT-only interventions with the sedentary activity intervention to see if MF and HIIT has beneficial effects on children's EF.
Further, researcher will compare the EF measures following the MF-HIIT compared with MF-only and HIIT-only interventions to see if combining MF with HIIT has greater beneficial effects on children's EF than MF and HIIT alone.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Shih-Chun (Alvin) Kao, PhD
- Phone Number: 765-496-2213
- Email: kao28@purdue.edu
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University
-
Contact:
- Shih-Chun (Alvin) Kao
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 10-12 years old
- Intelligence Quotient ≥ 85
- Capable of performing exercise based on pre-participation health screening
- No formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)
Exclusion Criteria:
- Age outside of the range of 10-12 years old
- Intelligence Quotient < 85
- No capable of performing exercise based on pre-participation health screening
- Has formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 12-Week Mindful High-Intensity Interval Training (MF-HIIT)
|
Two 10-min MF-HIIT sessions every school day during the 12-week intervention period.
One session in the morning and one session in the afternoon.
|
Active Comparator: 12-Week High-Intensity Interval Training (HIIT-only)
|
Two 10-min HIIT-only sessions every school day during the 12-week intervention period.
One session in the morning and one session in the afternoon.
|
Active Comparator: 12-Week Mindfulness (MF-only)
|
Two 10-min MF-only sessions every school day during the 12-week intervention period.
One session in the morning and one session in the afternoon.
|
Placebo Comparator: 12-Week Sedentary Activities
|
Two 10-min sedentary sessions every school day during the 12-week intervention period.
One session in the morning and one session in the afternoon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inhibition speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Inhibition speed will be assessed by the response time (ms) during a child-friendly flanker task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Updating speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Updating speed will be assessed by the response time (ms) during a child-friendly n-back task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Shifting speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Shifting speed will be assessed by the response time (ms) during a child-friendly switching task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Inhibition accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Inhibition accuracy will be assessed by the response accuracy (percent) during a child-friendly flanker task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Updating accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Updating accuracy will be assessed by the response accuracy (percent) during a child-friendly n-back task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Shifting accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Shifting accuracy will be assessed by the response accuracy (percent) during a child-friendly switching task.
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aerobic capacity
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Aerobic capacity will be assessed by the Progressive Aerobic Cardiovascular Endurance Run (PACER) test
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Upper body muscle endurance
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Upper body muscle endurance will be assessed by the push-ups test
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Core body muscle endurance
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Core body muscle endurance will be assessed by the curl-ups test
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Flexibility
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Flexibility will be assessed by the back-saver sit and reach test
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Body composition
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
body composition will be assessed by the body mass index computed as weight (kg) / (height [m] * height [m])
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Dispositional mindfulness
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Dispositional mindfulness will be assessed by the Child and Adolescent Mindfulness Measure questionnaire (CAMM).
The questionnaire has 10 items and requires the respondents to rating each item using a 5-point likert scale from 0 (Never True) to 4 (Always True).
Higher summed scores indicate higher levels of mindfulness
|
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB-2023-1683
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on MF-HIIT
-
Purdue UniversityUniversity of OregonNot yet recruiting
-
Bausch & Lomb IncorporatedCompleted
-
University of Erlangen-Nürnberg Medical SchoolUnknownMetabolic Syndrome | Overweight and ObesityGermany
-
Coopervision, Inc.Completed
-
Campus Bio-Medico UniversityUniversity of Rome Tor Vergata; University Hospital of Ferrara; Arcispedale Santa... and other collaboratorsTerminatedIschemic Stroke | Stroke, AcuteItaly
-
Alcon ResearchCompleted
-
VA Office of Research and DevelopmentNot yet recruitingDepression | Anxiety | Post Traumatic Stress Disorder (PTSD)United States
-
University of SevilleRecruitingInsulin Growth Factor I Deficiency | IGF1 Deficiency | Executive Function DisorderSpain
-
USDA Grand Forks Human Nutrition Research CenterCompletedObesity | OverweightUnited States
-
Karolinska InstitutetWithdrawn